ストックスクリーナーアプリを入手
29.75
2.37%
0.69
Alkermes Plc (ALKS) 最新ニュース
After culling 90% of staff, Waltham biotech finds buyer - NBC Boston
Opioid Use Disorder Market: Generated Opportunities and Future Scope by 2032 | Indivior PLC, Alkermes, Orexo AB - openPR.com
Chart Analysts Warn of Resistance Near Alkermes plc PriceWeekly Market Outlook & Community Driven Trade Alerts - kangso.co.kr
Will Lowered Earnings Forecasts Shift Alkermes' (ALKS) Valuation Story or Reinforce Investor Caution? - simplywall.st
Price Floor Holding on Alkermes plc — Rebound PossibleQuarterly Portfolio Review & Daily Profit Maximizing Trade Tips - 선데이타임즈
Visual analytics tools that track Alkermes plc performance2025 Winners & Losers & Daily Growth Stock Investment Tips - Newser
Visual trend scoring systems applied to Alkermes plcJuly 2025 Update & Weekly Stock Breakout Alerts - Newser
Intraday pattern recognizer results for Alkermes plcJuly 2025 Summary & Stock Timing and Entry Methods - Newser
What’s the recovery path for long term holders of Alkermes plcGap Down & Safe Entry Point Alerts - Newser
Investors Don't See Light At End Of Alkermes Plc's (NASDAQ:ALKS) Tunnel - 富途牛牛
Is Alkermes plc stock influenced by commodity prices2025 Trading Volume Trends & Pattern Based Trade Signal System - thegnnews.com
Charles Schwab Investment Management Inc. Sells 21,558 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
PNC Financial Services Group Inc. Has $408,000 Stock Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World
Vanguard Group Inc. Sells 283,511 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Live Scanner Shows Breakout on Alkermes plcMarket Surge Signal for Swing Traders Triggered - metal.it
Is Alkermes plc in a long term uptrendWealth Leverage Stock List - mustnews.co.kr
Avantax Advisory Services Inc. Makes New $246,000 Investment in Alkermes plc (NASDAQ:ALKS) - Defense World
BlackRock increases stake in Alkermes to 17% - Investing.com India
BlackRock increases stake in Alkermes to 17% By Investing.com - Investing.com Nigeria
Alkermes plc Ireland - AD HOC NEWS
Alkermes plc Included in Top Momentum ScanInvestment Strategy Designed for Capital Protection - metal.it
Chondrosarcoma Market: Epidemiology, Pipeline Products, - openPR.com
Alkermes plc Announces Pricing of New Term Loans - AOL.com
HC Wainwright Brokers Boost Earnings Estimates for Alkermes - Defense World
What markets is AAON Inc. expanding into Is Alkermes plc stock a good long term investment optionBuild a diversified portfolio for steady growth - Jammu Links News
What is the dividend policy of Alkermes plc stockUnmatched market gains - Jammu Links News
Is Alkermes plc a growth stock or a value stockInvest smarter with expert trading signals - Jammu Links News
What makes Alkermes plc stock price move sharplyInvest confidently with professional advice - Jammu Links News
Is Alkermes plc stock overvalued or undervaluedGet exclusive access to expert stock recommendations - Jammu Links News
Alkermes Q2 Earnings Beat Estimates, Proprietary Drugs Aid Sales - MSN
What catalysts could drive Alkermes plc stock higher in 2025Invest confidently with professional advice - Jammu Links News
Should I hold or sell Alkermes plc stock in 2025Get expert analysis on top stock picks - Jammu Links News
Needham & Company LLC Reaffirms "Buy" Rating for Alkermes (NASDAQ:ALKS) - MarketBeat
How does Alkermes plc generate profit in a changing economyBuild capital through low-risk investments - Jammu Links News
What are analysts’ price targets for Alkermes plc in the next 12 monthsAchieve rapid portfolio growth with expert guidance - Jammu Links News
What are the technical indicators suggesting about Alkermes plcDiscover investment plans that deliver results - Jammu Links News
How strong is Alkermes plc company’s balance sheetUnlock powerful portfolio optimization tools - Jammu Links News
What markets is Alkermes plc expanding into Is ASLE stock a good long term investment optionBuild a portfolio that outperforms consistently - Jammu Links News
Alkermes Reports Q2 2025 Financial Results, Reiterates Expectations and Highlights Positive Clinical Study Results - AInvest
ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Alkermes plc To Contact The Firm - ACCESS Newswire
Alkermes shares climb 5% following Q2 earnings and revenue beat - MSN
(07/31/25) ALKS: Positive Narcolepsy Drug Trial Puts this Biotech Name in F - moneyshow.com
Alkermes anticipates record proprietary product sales above $1B for 2025 as orexin pipeline advances - MSN
Alkermes: A More Than Solid Quarter (NASDAQ:ALKS) - Seeking Alpha
Alkermes stock price target raised to $42 from $40 at RBC Capital - Investing.com Nigeria
Alkermes plc (NASDAQ:ALKS) Q2 2025 Earnings Call Transcript - Insider Monkey
Alkermes Beat Expectations With A Strong Second Quarter - Finimize
Schizophrenia Drugs Market Exclusive Report with Detailed - openPR.com
Alkermes PLC (ALKS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Alkermes: Q2 Earnings Snapshot - Norwalk Hour
Alkermes Reports Strong Q2 2025 Financial Results - TipRanks
2.40%
0.37%
大文字化:
|
ボリューム (24 時間):